Labshake search
Citations for Tocris :
1 - 50 of 213 citations for VIP Antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 1µM VIP (Tocris) dissolved in sterile water was applied at CT14 to the culture medium 15 mins prior to 200µM RG108 (dissolved in 0.66% DMSO ...
-
bioRxiv - Physiology 2020Quote: ... 10 nM VIP (Tocris), 10 nM PYY (Phoenix Pharmaceuticals ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Immunology 2024Quote: ... media+IL4+LPS+VIP (50ng/ml, Tocris 1911) or ...
-
bioRxiv - Physiology 2020Quote: ... Media was changed to include 10 nM VIP (Tocris). In some experiments ...
-
bioRxiv - Neuroscience 2019Quote: ... antagonist CGP-52432 (Tocris Cookson) and GABA transporter inhibitor NNC-771 (Tocris Cookson ...
-
bioRxiv - Cancer Biology 2020Quote: ... RXR antagonist HX531 from Tocris, siRNA SMARTpools from Dharmacon (siRNA sequences are available upon request) ...
-
bioRxiv - Neuroscience 2020Quote: ... GRPR antagonist RC-3095 (Tocris) was dissolved in 0.1% DMSO in saline to 2µg/µl and injected intraperitoneally at 10µg/g of body weight 30 minutes before behavioral evaluation ...
-
bioRxiv - Cell Biology 2020Quote: ... or antagonist (CGP-12177, Tocris) (alprenolol ...
-
bioRxiv - Physiology 2024Quote: ... CXCR2 antagonist (1 nM; Tocris).
-
Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signalingbioRxiv - Neuroscience 2022Quote: ... TCN201 (GluN2A antagonist, Cat. No.4154), Ro25-6981 (GluN2B antagonist, Cat. No.1594) from Tocris, and recombinant hevin from RD system (Cat ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... NBQX (25 μM, AMPAR antagonist, Tocris), D-AP5 (50 μM ...
-
bioRxiv - Neuroscience 2019Quote: ... GABAB antagonist CGP 35348 (200µM) (Tocris) was added to the bath ...
-
bioRxiv - Genetics 2022Quote: ... PTGIR antagonist (Ro 1138452 hydrochloride; Tocris), PTGER4 agonist (CAY10684 ...
-
bioRxiv - Immunology 2019Quote: ... CATPB (FFA2R antagonist) was from Tocris Bioscience (Bristol ...
-
bioRxiv - Cell Biology 2022Quote: ... T0070907 (PPARγ antagonist) (all from Tocris) and betulin (inhibitor of SREBP maturation ...
-
bioRxiv - Neuroscience 2023Quote: CB1 antagonist AM251 (1mg/kg; Tocris) and TRPV1 antagonist Capsazepine (5mg/kg ...
-
bioRxiv - Neuroscience 2022Quote: ... The α7nAChR-selective antagonist MLA (1029; Tocris) was dissolved in saline to make a 10 mM stock solution ...
-
bioRxiv - Immunology 2021Quote: ... and AT1 receptor antagonist Candesartan cilexetil (Tocris) were used in this study ...
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (50 μM, NMDAR antagonist, Tocris), CGP 55845 were added into ACSF solution ...
-
bioRxiv - Neuroscience 2021Quote: ... 50 µM SR16584 (α3β4* nAChR antagonist, Tocris), and 5 nM methyllycaconitine (MLA ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 µM DHβE (α4β2* nAChR antagonist, Tocris), 50 µM SR16584 (α3β4* nAChR antagonist ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Selective opioid antagonists were purchased from Tocris Bioscience ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 receptor antagonist SB328437 (Tocris Bioscience) was added at a final concentration of 10 μM (41) ...
-
bioRxiv - Cancer Biology 2022Quote: ... A2AR antagonist SCH-58261 (Tocris, bio-techne) or placebo (sterile PBS containing 0.005% DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... and eticlopride hydrochloride (Tocris Bioscience; D2R antagonist) was administered systemically at doses of 0.01 mg/kg and 0.03 mg/kg ...
-
bioRxiv - Neuroscience 2021Quote: ... SCH 23390 hydrochloride (Tocris Bioscience; D1R antagonist) was administered systemically at doses of 0.005mg/kg and 0.01mg/kg ...
-
bioRxiv - Neuroscience 2020Quote: ... GABAAR antagonist picrotoxin (100 μM, Tocris-1128), and NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid 50 μM ...
-
bioRxiv - Immunology 2020Quote: ... NR agonists/antagonists: NR1I2 agonist SR12813 (Tocris), NR1I2 antagonist SPA70 (Axon) ...
-
bioRxiv - Neuroscience 2021Quote: ... CGP55845 (GABAB antagonist; all from Tocris, USA), 5-HT ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAB receptor antagonist CGP55845 (3 μM, Tocris), Na+ channel blocker tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... or the inverse agonist/antagonist AM630 (Tocris, Bristol ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Neuroscience 2023Quote: ... The NMDA antagonist APV (20μM, Tocris Bioscience) and AMPA/kainate antagonist CNQX (10 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... the GABABR antagonist CGP55845 (Tocris; 10 M) or the L-type voltage-gated calcium channel blocker nifedipine (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... or antagonist MCPG (500 µM113; Tocris Bioscience) was injected through the silicone port of the cranial window using a glass pipette ...
-
bioRxiv - Cancer Biology 2024Quote: ... and G15 (GPER/GPR30 antagonist) from Tocris Bioscience was used at 1 uM/mL ...
-
bioRxiv - Immunology 2024Quote: ... MA). PAR1 antagonist RWJ65110 (Catalog no. 2614) and PAR4 antagonist tcY-NH2 (Catalog no. 1488) were purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Immunology 2019Quote: ... and/or VIPR2 ligands (BAY-559837: 1-100nM, and VIP: 1nM-1uM, TOCRIS) for 16h (37°C) ...
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Neuroscience 2022Quote: ... or the D2 antagonist raclopride (Tocris Bioscience, UK). Ecopipam hydrobromide was given in the dose of 0.1 mg/kg as a free base and raclopride was given at the dose of 0.25 mg/kg ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 antagonist SB328437 (10 mM, Tocris Bioscience) and/or the CCR10 antagonist BI-6901 (20 mM ...
-
bioRxiv - Neuroscience 2022Quote: ... and the TAAR1 antagonist EPPTB (1 μM, Tocris) in ACSF ...
-
bioRxiv - Biochemistry 2022Quote: ... and the low-affinity antagonist SSR 149415 (Tocris) was added to a final concentration of 100 μM and the suspension was incubated for 30 min ...
-
bioRxiv - Neuroscience 2020Quote: ... AMPAR antagonists ZK200775 (2 nM, Tocris, Cat# 2345) and kynurenic acid (0.1 mM ...
-
bioRxiv - Neuroscience 2020Quote: ... NK1R antagonist CP 99994 (18 μg, Tocris, 3417). Sterile saline was delivered as a vehicle control.
-
bioRxiv - Neuroscience 2019Quote: MOR antagonist: cyprodime HCl (10 mg/kg; Tocris) dissolved in 10% dimethyl sulfoxide (DMSO).
-
bioRxiv - Neuroscience 2019Quote: DOR antagonist: naltrindole HCl (10 mg/kg; Tocris) dissolved in 10% DMSO.
-
bioRxiv - Neuroscience 2022Quote: ... CU-CPT22 (TLR antagonist; 2.5ug/dose; Tocris; 4884), and a cocktail of three different GSK3β inhibitors (referred to as ABC ...